<?xml version="1.0" encoding="UTF-8"?>
<search_results count="10">
  <query>Acne</query>
  <!-- Additional study fields may be added over time -->
  <study rank="1">
    <title>Preliminary Efficacy and Safety of Apremilast in the Treatment of Acne Conglobata</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Acne Conglobata</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Apremilast</intervention>
    </interventions>
    <locations>
      <location>University Hospital Frankfurt, Frankfurt, Hessia, Germany</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04161456</url>
  </study>
  <study rank="2">
    <title>Combined Treatment With CO2 Laser and Isotretinoin for Acne Scars</title>
    <status open="N">Active, not recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Acne Vulgaris</condition>
    </conditions>
    <interventions>
      <intervention type="Combination Product">Isotretinoin and CO2 laser</intervention>
      <intervention type="Device">Co2 laser</intervention>
    </interventions>
    <locations>
      <location>Tel Aviv sourasky medical center, Tel Aviv, Israel</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04870489</url>
  </study>
  <study rank="3">
    <title>Pharmacokinetics and Safety of ALA in Acne Vulgaris</title>
    <status open="Y">Recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Acne Vulgaris</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">ALA 5%</intervention>
      <intervention type="Drug">ALA 10%</intervention>
    </interventions>
    <locations>
      <location>Huashan Hospital, Shanghai, Shanghai, China</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04044898</url>
  </study>
  <study rank="4">
    <title>A Study of S6G5T-3 in the Treatment of Acne Vulgaris</title>
    <status open="N">Completed</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Acne Vulgaris</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">S6G5T-3</intervention>
      <intervention type="Drug">S6G5T-8</intervention>
    </interventions>
    <locations>
      <location>Dermatology Consulting Services, High Point, North Carolina, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT03761784</url>
  </study>
  <study rank="5">
    <title>Impact of the M22-IPL Acne Filter on Acne Vulgaris</title>
    <status open="N">Terminated</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Acne</condition>
    </conditions>
    <interventions>
      <intervention type="Device">M22-IPL</intervention>
    </interventions>
    <locations>
      <location>Knight Dermatology Institute, Orlando, Florida, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT02180282</url>
  </study>
  <study rank="6">
    <title>Comparison of Malassezia Spp Proportions in Inflammatory and Non Inflammatory Facial Acne Vulgaris Lesions</title>
    <status open="N">Completed</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Acne Vulgaris</condition>
    </conditions>
    <interventions>
      <intervention type="Other">Clinical and laboratory examination</intervention>
    </interventions>
    <locations>
      <location>Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Jakarta Pusat, DKI Jakarta, Indonesia</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04367584</url>
  </study>
  <study rank="7">
    <title>Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris</title>
    <status open="N">Completed</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Acne Vulgaris</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd)</intervention>
      <intervention type="Drug">ACZONEÂ® (dapsone) gel, 7.5% (Allergan, INC.)</intervention>
      <intervention type="Other">Placebo for Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd)</intervention>
    </interventions>
    <locations>
      <location>Unison Center for Clinical Trials, Sherman Oaks, California, United States</location>
      <location>MOORE Clinical Research, Inc., Brandon, Florida, United States</location>
      <location>FXM Clinical Research Miami, Miami, Florida, United States</location>
      <location>FXM Clinical Research Miramar, Miramar, Florida, United States</location>
      <location>MOORE Clinical Research, Inc. (S. Tampa Site), Tampa, Florida, United States</location>
      <location>MOORE Clinical Research, Inc. (Temple Terrace Site), Temple Terrace, Florida, United States</location>
      <location>Research Institute of Central Florida, Winter Park, Florida, United States</location>
      <location>Dermatology Consulting Services, PLLC, High Point, North Carolina, United States</location>
      <location>PEAK Research, LLC, Upper Saint Clair, Pennsylvania, United States</location>
      <location>3A Research, LLC - WEST, El Paso, Texas, United States</location>
      <location>3A Research, LLC - EAST, El Paso, Texas, United States</location>
      <location>Dermatology &amp; Skin Surgery Centre/ FXM Research International, Belize City, Belize</location>
      <location>Dr. Moguel's Clinic/ FXM Research International, Belize City, Belize</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04015375</url>
  </study>
  <study rank="8">
    <title>Study to Evaluate the Safety and Efficacy of ASC40 in Subjects With Moderate to Severe Acne Vulgaris</title>
    <status open="Y">Not yet recruiting</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Acne Vulgaris</condition>
    </conditions>
    <interventions>
      <intervention type="Drug">ASC40 25mg</intervention>
      <intervention type="Drug">ASC40 50mg</intervention>
      <intervention type="Drug">ASC40 75mg</intervention>
      <intervention type="Drug">Placebo</intervention>
    </interventions>
    <locations/>
    <url>https://ClinicalTrials.gov/show/NCT05104125</url>
  </study>
  <study rank="9">
    <title>Relationship of Whole Blood Zinc Levels to Acne Severity</title>
    <status open="N">Completed</status>
    <study_results>No Results Available</study_results>
    <conditions>
      <condition>Acne Vulgaris</condition>
    </conditions>
    <interventions>
      <intervention type="Diagnostic Test">Whole blood zinc level</intervention>
    </interventions>
    <locations>
      <location>East Avenue Medical Center, Quezon CIty, Metro Manila, Philippines</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT04975412</url>
  </study>
  <study rank="10">
    <title>A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris</title>
    <status open="N">Completed</status>
    <study_results>Has Results</study_results>
    <conditions>
      <condition>Acne Vulgaris</condition>
    </conditions>
    <interventions>
      <intervention type="Device">Acne Mask</intervention>
    </interventions>
    <locations>
      <location>Tennessee Clinical Research Center, Nashville, Tennessee, United States</location>
    </locations>
    <url>https://ClinicalTrials.gov/show/NCT03128723</url>
  </study>
</search_results>
